Anju Verma, MD
Endocrinology, Diabetes & Metabolism · Germantown, MDNPI 1396724696
Payments from drug & device makers
Across 2 payments — averaging $21.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Senseonics, Incorporated$30
- Medtronic$13
What the payments were for
- Food & beverage$43100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Senseonics, Incorporated | 1 | $30 |
| Medtronic | 1 | $13 |
How this compares
$43 in reported general payments places this provider in the 0th percentile of 235 endocrinology, diabetes & metabolism providers in Maryland.
See all endocrinology, diabetes & metabolism providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 116 | $226,410 |
| OzempicSemaglutide | 109 | $204,511 |
| JardianceEmpagliflozin | 139 | $188,944 |
| Tresiba Flextouch U-100Insulin Degludec | 74 | $91,152 |
| TradjentaLinagliptin | 89 | $89,399 |
| MounjaroTirzepatide | 46 | $82,382 |
| JanuviaSitagliptin Phosphate | 48 | $63,084 |
| Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp | 136 | $53,718 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 72 | $47,929 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $46,158 |
| JanumetSitagliptin Phos/Metformin Hcl | 30 | $39,559 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 38 | $33,981 |
| FarxigaDapagliflozin Propanediol | 22 | $29,975 |
| Humalog Kwikpen U-100Insulin Lispro | 29 | $15,248 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 158 | $13,952 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Germantown
- Jean ParkBaltimore$3.7M
- Michael DempseyRockville$2.7M
- Ilias SpanakisBaltimore$2.6M
- Helena RodbardRockville$2.4M
- Daniel GozziSuitland$1.2M
- Martin SarkarFrederick$1.1M
- Romeu AzevedoCamp Springs$1.1M
- Nicholas ArgentoLaurel$1.1M
- Philip LevinBaltimore$702K
- David BrownRockville$497K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.